Viewing Study NCT02303392

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2026-06-08 @ 3:45 PM
Study NCT ID: NCT02303392
Status: COMPLETED
Last Update Posted: 2025-06-10
First Post: 2014-11-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma
Sponsor: Jennifer Woyach
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prolymphocytic Leukemia View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Recurrent Small Lymphocytic Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
Keywords: